Calmark Sweden AB (FRA:9C7) Change In Receivables : €0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Calmark Sweden AB Change In Receivables?

Calmark Sweden AB's change in receivables for the quarter that ended in Sep. 2023 was €0.00 Mil. It means Calmark Sweden AB's Accounts Receivable stayed the same from Jun. 2023 to Sep. 2023 .

Calmark Sweden AB's change in receivables for the fiscal year that ended in Dec. 2022 was €0.07 Mil. It means Calmark Sweden AB's Accounts Receivable declined by €0.07 Mil from Dec. 2021 to Dec. 2022 .

Calmark Sweden AB's Accounts Receivable for the quarter that ended in Sep. 2023 was €0.17 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Calmark Sweden AB's liquidation value for the three months ended in Sep. 2023 was €-0.39 Mil.

Calmark Sweden AB Change In Receivables Historical Data

The historical data trend for Calmark Sweden AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calmark Sweden AB Change In Receivables Chart

Calmark Sweden AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Change In Receivables

0.08

-0.17

0.07

Calmark Sweden AB Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Change In Receivables	Get a 7-Day Free Trial									-	-	-	-	-

Calmark Sweden AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Calmark Sweden AB (FRA:9C7) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Calmark Sweden AB's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.174	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Calmark Sweden AB's accounts receivable are only considered to be worth 75% of book value:

Calmark Sweden AB's liquidation value for the quarter that ended in Sep. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.139	-	0.85	+	0.75 * 0.174	+	0.5 * 0.38
=	-0.39

Calmark Sweden AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of Calmark Sweden AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Calmark Sweden AB (FRA:9C7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Calmark Sweden AB (FRA:9C7) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CALMA B:Sweden

Address

Sommargatan 101A, Karlstad Innovation Park, lokal Manegen, Karlstad, SWE, SE-656 37

Website

https://www.calmark.se

Calmark Sweden AB provides tests for a newborn. The company's product Calmark's developed a point-of-care (POC) diagnostic instrument which makes it easier and faster to measure biomarkers for disease states in newborns. The company's PNA instrument consists of a reader and a disposable product that is placed in the reader when measured.

Calmark Sweden AB (FRA:9C7) Headlines

No Headlines